Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals
Terminated
University of Texas
Phase 1
Cocaine dependence is a major public health problem; an effective primary treatment for
cocaine dependent individuals has yet to be found. The purpose of this study is to determine
the safety and effects of vanoxerine (GBR 12909) in treating cocaine dependent individuals.
Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals
Terminated
National Institute on Drug Abuse (NIDA)
Phase 1
Cocaine dependence is a major public health problem; an effective primary treatment for
cocaine dependent individuals has yet to be found. The purpose of this study is to determine
the safety and effects of vanoxerine (GBR 12909) in treating cocaine dependent individuals.
Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm
Completed
Laguna Pharmaceuticals, Inc.
Phase 2
Evaluate the safety and efficacy of a single oral dose of vanoxerine compared to placebo, in
a dose modification manner, on the conversion of symptomatic atrial fibrillation (a-fib) or
flutter of recent onset to normal sinus rhythm.
Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus Rhythm
Terminated
Laguna Pharmaceuticals, Inc.
Phase 3
LGN-VN-003 is a prospective, multi-center, randomized, double-blind, placebo-controlled study
to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of
subjects with recent onset atrial fibrillation (AF) or atrial flutter (AFL) to normal sinus
rhythm. Up to 625 subjects will be randomized in a 2:1 fashion so at least 400 vanoxerine and
200 placebo subjects receive study drug.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
